QuidelOrtho shares have fallen 40.6% over the past six months to $16.68, driven by softer quarterly results. The company's constant currency revenue declined at an average annual rate of 3.4% over the last two years, signaling potential competitive pressures or market saturation. Its free cash flow margin fell by 23 percentage points over five years to negative 6% on a trailing 12-month basis, while return on invested capital has also decreased significantly. The stock now trades at 8.7 times forward earnings, but analysts caution that shaky fundamentals could pose further downside risk.
Quidel CorporationRevenue decline, negative free cash flow margin, and falling return on invested capital indicate weak fundamentals.